Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Altheus Therapeutics Inc.

www.altheustherapeutics.com

Latest From Altheus Therapeutics Inc.

Recent Financings of Private Companies, April 2012

START-UP 's monthly comprehensive review of emerging life science companies that have received venture funding during the month, including companies within the in vitro diagnostics, pharmaceuticals, research/analytical equipment & supplies, and medical device sectors.

BioPharmaceutical Medical Device

Start-Up Previews

This Month's Profile Group: VC-Backed GI Start-Ups See Opportunity In IBS features profiles of Altheus, AltheRx, Ardelyx and Second Genome. Plus these Start-Ups Across Health Care: InfraScan, PlaqueTec, Prosonix and Veracyte.

Altheus Therapeutics Inc.

If you can’t beat them, join them. Looks like the backers of Altheus Therapeutics Inc. see sound business sense in this homily: the start-up is working to create a potent new treatment for ulcerative colitis by combining N-acetylcysteine, an anti-inflammatory compound, with the aspirin derivative mesalamine, which for decades has been the front-line therapy for the condition.

BioPharmaceutical

Emergings In Brief (05/2008)

Brief profiles of these recently formed companies: Accord Biomaterials, Altheus Therapeutics, Astute Medical, and BioCure Pharma.
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Gastrointestinal
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Altheus Therapeutics Inc.
  • Senior Management
  • Dennis Schafer, Pres. & CEO
  • Contact Info
  • Altheus Therapeutics Inc.
    Phone: (405) 319-8180
    755 Research Pkwy.
    Ste. 435
    Oklahoma City, OK 73104
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register